Select Page

Biogelx CEO Mitch Scanlan: how synthetic bioinks will drive bioprinting forward

Written by David

March 6, 2019

Biogelx Mitch Scanlan Interview Born as a spin-out of the University of Strathclyde, Scotland-based Biogelx is pioneering the development of tunable synthetic materials for 3D bioprinting applications. The startup, which has been developing synthetic peptide hydrogels since 2013, is now preparing to commercially launch its first bioinks, suitable for a range of bioprinting applications. In the lead up to the launch, we spoke to Biogelx CEO Mitch Scanlan about the company’s goals and ambitions within the emerging bioprinting sphere as well as how its synthetic biomaterials offer a number of advantages over more common natural hydrogels. As became clear through our conversation, Biogelx see huge potential in the bioprinting market and is keeping a keen eye on the industry’s future but is also focusing on current applications for its innovative bioprinting products. Taking on commercialization “I spent 35 years working in life sciences,” Scanlan begins, giving some background on […]


Submit a Comment

Your email address will not be published. Required fields are marked *

You May Also Like…

Pin It on Pinterest

Share This

Share this post with your friends!